FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

READ MORE
 

FDA Authorizes Novavax COVID Vaccine

COVID-19 Has More People Going Cashless

With public worrying about the COVID-19 virus, the use of…
Read more

What’s in the EU-UK Brexit Deal?

After long months of negotiations, the EU and UK have a Brexit…
Read more

Iran to Move Forward With Uranium Enrichment

Iran has said it plans to increase uranium enrichment up…
Read more